KRAS and non-small cell lung carcinoma: To experimentally address this limitation and to examine the BRMS1 specific effects in regulating cell migration and invasion, we chose to exploit two established genetic alterations observed in human NSCLC - the loss of the p53 tumor suppressor and gain-of function mutation in the K-Ras allele [16].